ASH News Daily - Monday, December 12, 2011 - (Page B-16)

ASH NewS DAily ® Now Recruiting…… A New Clinical Trial for Patients with High-risk Smoldering Multiple Myeloma FocuS on early-career hematologiStS 2011 Special Events And Services for Trainees An important part of ASH’s mission is to support education and training in hematology. ASH provides valuable learning opportunities for hematology fellows, residents, medical students, and trainees during this year’s annual meeting. If you are a hematologist in training, plan to attend one or all of these events. once these sessions are filled. Drug Development – Bench to Bedside and Beyond San Diego Convention Center, Room 31 John Leonard, MD, Cornell University How to Publish a Manuscript in a Peer-Reviewed Journal San Diego Convention Center, Room 33 Cindy Dunbar, MD, Editor inChief, Blood Trainee Lounge San Diego Convention Center, Sails Pavilion, Upper Level The lounge provides a relaxing place for trainees to meet with colleagues, access the Internet, and recharge with complimentary refreshments. Trainee Lounge Hours Today: 7:00 a.m. - 6:00 p.m. Tuesday: 7:00 a.m. - 12:00 noon About Smoldering Multiple Myeloma (SMM) Smoldering multiple myeloma (SMM) is an asymptomatic condition that over time will transition into the malignant disease of multiple myeloma (MM). Study Overview Janssen Research, a unit of Centocor Research and Development, Inc., is conducting a study on SMM. In a global study 50 high-risk SMM subjects will be randomized to study drug and 50 subjects will be randomized to placebo (same drug without active ingredient). The study is double-blind, that is both doctors and patients will not know if the study drug or placebo will be given. The study intends to evaluate and/or follow subjects for 4-5 years. Trainee Simultaneous Didactic Sessions 12:15 - 1:15 p.m. Didactic sessions are designed to offer trainees an overview of timely and relevant career-oriented issues. A boxed lunch will be provided. Space is available on a first-come, first-served basis. As seating is limited, attendees are strongly encouraged to arrive early. No additional persons will be allowed in the rooms Primary Objective The primary objective of the study is to evaluate the 1-year progression-free survival (PFS) rate in patients with smoldering multiple myeloma (MM) with an investigational medication. On-Demand Webcasts n-demand webcasts of all of the Education Program sessions and the Special Lectures from this year’s annual meeting will be available on the ASH website (www.hematology.org) after the meeting. Users will be able to hear audio recordings of the presentations while viewing associated color slides. Sessions that will be captured for the Web are as follows: • All Education Program Sessions, including “Grant Writing for Junior Faculty” and “JuniorFaculty Development: Mentorship - How to Receive It, How to Provide It, How to Optimize It” • Education Spotlight Sessions • Presidential Symposium • Ham-Wasserman Lecture • Presentation of the Wallace H. Coulter Award for Lifetime Achievement in Hematology • E. Donnall Thomas Lecture O Major Inclusion Criteria ■ Diagnosis of SMM for < 4 years ■ Diagnosis of high-risk SMM; ■ ECOG Performance score of 0 or 1 Study Design 100 patients(1:1) • Ernest Beutler Lecture • ASH/EHA Joint Symposium • Trainee Simultaneous Didactic Sessions • Special Symposium on Basic Science of Hemostasis and Thrombosis • Special Symposium from the Quality of Care Subcommittee Quality Indicators – Examples and Relevance to Hematology • Practice Forum On-Demand Webcast Pricing The On-Demand Webcast can be purchased online during the registration process or on site at the prices listed below. Members (Active and International) – $65 Associate Members – $30 Non-Members – $275 Non-Members in Training – $60 Allied Health Professionals – $175 Receive investigational medication as an infusion every 4 weeks Receive placebo as an infusion every 4 weeks About the Investigative Medication The investigational medication is a monoclonal antibody that binds to IL-6. For more information, please email: mbalvers@its.jnj.com or btromp@its.jnj.com SMM-2001-ENG15 Version 1.0, 17JUN2011 Did you know you can access ASH News Daily from your laptop, tablet, or mobile phone? Check your email each morning, and click on the link from your device.  http://www.hematology.org

Table of Contents for the Digital Edition of ASH News Daily - Monday, December 12, 2011

ASH News Daily - Monday, December 12, 2011

https://www.nxtbookmedia.com